Secukinumab-induced paradoxical hidradenitis suppurativa successfully treated with adalimumab. Babino G, D'Ambra I, Fulgione E, Alfano R, et al. Int J Dermatol 2022;61:e79-e80.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Babino G, D'Ambra I, Fulgione E, Alfano R, et al. Secukinumab-induced paradoxical hidradenitis suppurativa successfully treated with adalimumab. Int J Dermatol 2022;61:e79-e80.
PMID: 34258759